BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20951488)

  • 1. A 90-year-old man with hyperphosphatemia.
    Lovekar S; Chen JL
    Am J Kidney Dis; 2011 Feb; 57(2):342-6. PubMed ID: 20951488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spuriously high phosphate level which is promptly resolved after plasmapheresis in a patient with multiple myeloma.
    Kiki I; Gundogdu M; Kaya H
    Transfus Apher Sci; 2007 Oct; 37(2):157-9. PubMed ID: 18037346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohyperphosphatemia and dysproteinemia.
    Busse JC; Gelbard MA; Byrnes JJ; Hellman R; Vaamonde CA
    Arch Intern Med; 1987 Nov; 147(11):2045-6. PubMed ID: 3675108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phosphate disorders: hyperphosphatemia or pseudohyperphosphatemia?].
    Aeberhard N; Schild C; Rodondi N; Roten-Joss C; Tänzler K
    Praxis (Bern 1994); 2014 Oct; 103(20):1203-6. PubMed ID: 25270750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erroneous determination of hyperphosphatemia ('pseudohyperphosphatemia') in sera of patients that have been treated with liposomal amphotericin B (AmBisome).
    Jensen GM; Bunch TH; Wolf S; Laybourne S
    Clin Chim Acta; 2010 Dec; 411(23-24):1900-5. PubMed ID: 20655888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudohyperphosphatemia in a hyperphosphatemic hemodialysis patient.
    Suchin EJ; Cizman B; Connolly BR; DiBattista WJ; Agus ZS
    Am J Kidney Dis; 2002 Nov; 40(5):E18. PubMed ID: 12407666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spurious hyperphosphatemia: a case for caution.
    Aiyer R; Kazory A
    Am J Kidney Dis; 2012 Dec; 60(6):1050-1. PubMed ID: 23084927
    [No Abstract]   [Full Text] [Related]  

  • 8. How paraproteins can affect laboratory assays: spurious results and biological effects.
    King RI; Florkowski CM
    Pathology; 2010; 42(5):397-401. PubMed ID: 20632813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudohyperphosphatemia in a patient with multiple myeloma.
    Marcu CB; Hotchkiss M
    Conn Med; 2004 Feb; 68(2):71-2. PubMed ID: 15007869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
    Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G
    J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spurious hyperphosphatemia in multiple myeloma].
    Jarchovsky I; Beitner H; Plavnick L
    Harefuah; 1991 Dec; 121(12):515-6. PubMed ID: 1794758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of serum-phosphate concentration in immunoglobulin G monoclonal gammopathy after PEG-precipitation.
    Chakraborty S; Kallner A
    Clin Chim Acta; 2015 Feb; 440():211-3. PubMed ID: 25490694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia.
    Tian X; Zhao L; Ma J; Lu J; Zhu TY; Liu Y; Sun HX
    Lab Med; 2023 Nov; 54(6):598-602. PubMed ID: 36942666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to the evaluation of hyperphosphatemia in chronic kidney disease.
    Savica V; Calò LA; Granata A; Caldarera R; Cavaleri A; Santoro D; Monardo P; Savica R; Muraca U; Bellinghieri G
    Clin Nephrol; 2007 Oct; 68(4):216-21. PubMed ID: 17969488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophosphatemia associated with paraproteinemia: a case report and review of the literature.
    Kerr S; Kindt J; Daram SR
    WMJ; 2007 Dec; 106(8):490-3. PubMed ID: 18237074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].
    Michigami T
    Clin Calcium; 2009 Jun; 19(6):785-92. PubMed ID: 19483272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal involvement in monoclonal gammopathy and multiple myeloma].
    De Sanctis LB; Sestigiani E; Sgarlato V; Fabbrizio B; Santoro A
    G Ital Nefrol; 2010; 27 Suppl 50():S19-33. PubMed ID: 20922692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma.
    Sonnenblick M; Eylath U; Brisk R; Eldad C; Hershko C
    Clin Chem; 1986 Aug; 32(8):1537-9. PubMed ID: 3731447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohyperphosphatemia in a patient with multiple myeloma.
    Lee Y; Koo T; Yi JH; Choi JH; Han SW; Park IK; Kim HJ
    Electrolyte Blood Press; 2007 Dec; 5(2):131-5. PubMed ID: 24459512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST).
    Penne EL; van der Weerd NC; van den Dorpel MA; Grooteman MP; Lévesque R; Nubé MJ; Bots ML; Blankestijn PJ; ter Wee PM;
    Am J Kidney Dis; 2010 Jan; 55(1):77-87. PubMed ID: 19962805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.